Table 3.
Performance on Chronic Care Quality Indicators: Overall and by Tumor Type
| Chronic Care Indicators | Overall |
Breast |
Prostate |
Colorectal |
||||
|---|---|---|---|---|---|---|---|---|
| No. Receiving Appropriate Care/No. Eligible for Indicator | % | No. Receiving Appropriate Care/No. Eligible for Indicator | % | No. Receiving Appropriate Care/No. Eligible for Indicator | % | No. Receiving Appropriate Care/No. Eligible for Indicator | % | |
| Visit every 6 months for patients with chronic stable angina | ||||||||
| Cases | 389/449 | 87 | 80/86 | 93 | 174/200 | 87 | 135/163 | 83 |
| Controls | 886/1,038 | 85 | 178/191 | 93 | 450/552 | 82 | 258/295 | 88 |
| Visit every 6 months for patients with congestive heart failure | ||||||||
| Cases | 884/1,031 | 86 | 193/213 | 91 | 269/309 | 87 | 422/509 | 83 |
| Controls | 1,471/1,734 | 85 | 365/415 | 88 | 662/800 | 83 | 444/519 | 86 |
| Visit every 6 months for patients with chronic obstructive pulmonary disease | ||||||||
| Cases | 1,054/1,281 | 82 | 236/263 | 90 | 449/528 | 85 | 369/490 | 75 |
| Controls | 1,499/1,909 | 79 | 335/406 | 83 | 721/968 | 75 | 443/535 | 83 |
| Visit every year for patients with diagnosis of transient ischemic attack | ||||||||
| Cases | 259/266 | 97 | 53/53 | 100 | 101/105 | 96 | 105/108 | 97 |
| Controls | 507/534 | 95 | 137/141 | 97 | 220/238 | 92 | 150/155 | 97 |
| Cholesterol test every 6 months for patients hospitalized for acute myocardial infarction and who have hypercholesterolemia | ||||||||
| Cases | — | 16 | — | 60 | — | 10 | — | 10 |
| Controls | 22/105 | 21 | — | 5 | — | 21 | 10/32 | 31 |
| Lipid profile ≤ 1 year after initial diagnosis of angina | ||||||||
| Cases | 308/449 | 69 | 58/86 | 67 | 151/200 | 76 | 99/163 | 61 |
| Controls | 755/1,038 | 73 | 143/191 | 75 | 396/552 | 72 | 216/295 | 73 |
| Visit every 6 months for patients with diabetes | ||||||||
| Cases | 1,696/1,984 | 86 | 367/398 | 92 | 817/971 | 84 | 512/615 | 83 |
| Controls | 3,037/3,769 | 81 | 645/767 | 84 | 1,461/1,919 | 76 | 931/1,083 | 86 |
| Eye examination every year for patients with diabetes | ||||||||
| Cases | 884/1,984 | 45 | 193/398 | 49 | 433/971 | 45 | 258/615 | 42 |
| Controls | 1,739/3,769 | 46 | 395/767 | 52 | 815/1,919 | 43 | 529/1,083 | 49 |
| Glycosylated hemoglobin or fructosamine every 6 months for patients with diabetes | ||||||||
| Cases | 536/1,984 | 27 | 103/398 | 26 | 271/971 | 28 | 162/615 | 26 |
| Controls | 1,070/3,769 | 28 | 223/767 | 29 | 509/1,919 | 27 | 338/1,083 | 31 |
| No avoidable outcome | ||||||||
| Cases | 2,996/3,740 | 80 | 597/751 | 79 | 1,468/1,676 | 88 | 931/1,313 | 71 |
| Controls | 5,075/6,459 | 79 | 1,086/1,402 | 77 | 2,563/3,205 | 80 | 1,426/1,852 | 77 |
NOTE. BOLD indicates statistically significantly (P < .05) better in comparison between cases and controls based on Fisher's exact test.
(—) Numerator and denominator suppressed to protect confidentiality because of small cell sizes.